Search results
7 maj 2020 · What was more readily available, at least in the Southern Hemisphere in 2009, was the 2009 seasonal inactivated influenza vaccine containing the seasonal A(H1N1) virus, that was later found to have modest efficacy against the A(H1N1)pdm09 virus (38% (95% CI: 19%, 53%)) .
1 lip 2015 · If a vaccine can trigger narcolepsy, can the flu virus itself—either H1N1 or other influenza strains? Cases of narcolepsy increased after the 2009 pandemic in China, where Pandemrix wasn't used, and researchers discovered that serum from some H1N1 influenza patients does bind to the hypo cretin receptor.
2 cze 2020 · The article traces the emergence of a new type of vaccine injury—vaccine-associated narcolepsy—following immunization with Pandemrix vaccine during the 2009 H1N1 pandemic in Europe.
Ten weeks into the worldwide immunization campaign against pandemic (H1N1) 2009, the GACVS reviewed the safety of pandemic (H1N1) 2009 vaccines currently in use. To date, the safety data are reassuring. Most of the adverse events that have been reported after immunization have not been serious.
27 paź 2021 · A range of monovalent influenza A H1N1pdm09 vaccines with or without adjuvants were developed. After the mass vaccination campaigns safety concerns related to H1N1pdm09 vaccines were reported. More than a decade later, reported AEFIs are still under scrutiny.
9 cze 2021 · Influenza vaccines have been our primary tool for infection control to prevent seasonal epidemics and pandemics such as the 2009 H1N1 influenza A virus pandemic. Certain high-risk populations, including the elderly, people with obesity, and individuals with comorbidities such as type 2 diabetes mellitus, are more susceptible to increased ...
15 kwi 2009 · Not choosing to get the vaccine, does one more harm than good and one should remain informed on how to better protect themselves. Vaccinations are imperative to ensure the safety of our children, the immunocompromised as well as our geriatric patients.
